Mary E. Abood

Overview

Best Publications

• International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

  Roger Guy Pertwee;A. C. Howlett;M. E. Abood;S. P. H. Alexander

  1934
  Citations

• Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

  V M Showalter;D R Compton;B R Martin;M E Abood

  741
  Citations

• Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves.

  Edward J.N. Ishac;Liu Jiang;Kristy D. Lake;Karoly Varga

  448
  Citations

• Neurobiology of marijuana abuse

  Mary E. Abood;Billy R. Martin

  348
  Citations

• 3-(1′,1′-Dimethylbutyl)-1-deoxy-Δ8-THC and related compounds: synthesis of selective ligands for the CB2 receptor

  John W. Huffman;John Liddle;Shu Yu;Mie Mie Aung

  348
  Citations

• Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding

  Mie Mie Aung;Graeme Griffin;John W Huffman;Ming-Jung Wu

  342
  Citations

• Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.

  Norbert E. Kaminski;Mary E. Abood;Fay K. Kessler;Billy R. Martin

  320
  Citations

• CB1 and CB2 Receptor Pharmacology

  Allyn C. Howlett;Mary E. Abood

  317
  Citations

• Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.

  Ankur Kapur;Pingwei Zhao;Haleli Sharir;Yushi Bai

  304
  Citations

• Functional homology between signal-coupling proteins. Cholera toxin inactivates the GTPase activity of transducin.

  M E Abood;J B Hurley;M C Pappone;H R Bourne

  283
  Citations

• Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor.

  Graeme Griffin;Qing Tao;Mary E. Abood

  270
  Citations

• Pharmacological characterization of GPR55, a putative cannabinoid receptor.

  Haleli Sharir;Mary E. Abood

  267
  Citations

• An Aromatic Microdomain at the Cannabinoid CB1 Receptor Constitutes an Agonist/Inverse Agonist Binding Region

  Sean D. McAllister;Gulrukh Rizvi;Sharon Anavi-Goffer;Dow P. Hurst

  245
  Citations

• Synthesis and Pharmacology of a Very Potent Cannabinoid Lacking a Phenolic Hydroxyl with High Affinity for the CB2 Receptor

  John W. Huffman;Shen Yu;Vincent Showalter;Mary E. Abood

  216
  Citations

• The endocannabinoid system as a target for the treatment of neurodegenerative disease

  Emma L Scotter;Mary E Abood;Michelle Glass

  214
  Citations

• Cannabinoid receptors: nomenclature and pharmacological principles

  Linda Console-Bram;Jahan Marcu;Mary E. Abood

  213
  Citations

• Cannabinoid Receptors Can Activate and Inhibit G Protein-Coupled Inwardly Rectifying Potassium Channels in a Xenopus Oocyte Expression System

  Sean D. McAllister;Graeme Griffin;Leslie S. Satin;Mary E. Abood

  209
  Citations

• Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation.

  Sean D. McAllister;Dow P. Hurst;Judy Barnett-Norris;Diane L. Lynch

  200
  Citations

• Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system.

  Graeme Griffin;Emma J Wray;Qing Tao;Sean D McAllister

  196
  Citations

• Activation of GPR18 by cannabinoid compounds: a tale of biased agonism.

  Linda Console-Bram;Eugen Brailoiu;Gabriela Cristina Brailoiu;Haleli Sharir

  191
  Citations